Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)
- Type
- Retraction
- Notice date
- 3/31/2026 0:00
- Journal
- BMJ: British Medical Journal
- Publisher
- BMJ Publishing
- Notice DOI
- 10.1136/bmj.s579
- Original paper DOI
- 10.1136/bmj-2024-083382
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Human Subject Welfare
- Concerns/Issues about Methods
- Concerns/Issues about Results and/or Conclusions
- Conflict of Interest
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Unreliable Data
- Unreliable Results and/or Conclusions
- Upgrade/Update of Prior Notice(s)